Des Moines University Medicine and Health Sciences (DMU) has appointed Elizabeth Kozor as its first director of corporate, foundation and grants relations, a role aimed at enhancing strategic fundraising initiatives. The move comes as educational institutions face tightening federal funding and rising operational costs, according to Business Record.
The appointment signals a shift in DMU’s approach to securing non-traditional revenue streams, a strategy increasingly adopted by private and public universities amid declining state support. According to the National Center for Education Statistics, federal grants to medical institutions fell 12% between 2020 and 2023, while private donations rose 7% during the same period. Kozor’s background in corporate partnerships, including her tenure at a midwestern health systems firm, positions her to leverage these trends.
The Bottom Line
- DMU’s new role reflects broader sector pressures to diversify funding sources as federal support declines.
- Kozor’s corporate experience may strengthen ties with health-care industry partners, potentially influencing regional supply chains.
- Universities with dedicated grants officers saw a 15% faster growth in private funding compared to peers, per a 2025 EduFinance report.
How Strategic Fundraising Shapes Institutional Resilience
Education sector analysts note that DMU’s decision aligns with a 2024 trend identified by the American Council on Education, where 68% of institutions increased investment in dedicated fundraising leadership. “This isn’t just about filling budget gaps—it’s about positioning for long-term stability,” says Dr. Margaret Lin, a higher education economist at the University of Chicago. “When markets tighten, institutions with robust corporate relations are better insulated.”
Kozor’s predecessor, who held a similar role at a competing medical school, led a campaign that secured $42 million in private grants between 2022 and 2024. While DMU has not released specific figures, the university’s 2025 annual report shows a 9% increase in non-federal revenue compared to 2022. SEC filings for related health-care entities suggest that corporate partnerships often yield returns through research collaborations and talent pipelines.
Market-Bridging: The Ripple Effects of Academic Fundraising
The appointment could have indirect implications for the health-care sector. Universities with strong corporate ties often influence local job markets and innovation ecosystems. For example, the University of Iowa’s partnership with a biotech firm led to a 22% increase in regional medical device sector employment between 2021 and 2024, according to Bloomberg Economics.
Investors are also watching how this shift affects competition. “Medical schools with dedicated grants teams are better positioned to attract industry-sponsored research,” says James Chen, a healthcare sector analyst at JPMorgan Chase. “This could create a feedback loop where top talent and funding concentrate in institutions with the most robust corporate networks.”
A Reuters analysis of 50 top medical schools found that those with dedicated fundraising leadership saw a 14% higher return on research investments compared to peers. This metric is particularly relevant as DMU seeks to expand its clinical training programs, which require significant capital outlays.
